NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN

FDA Drug Profile — Bexsero

NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Bexsero. Available dosage form: injection, suspension.

Drug details

Generic Name
NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
Brand Names
Bexsero
Application Number
BLA125546
Sponsor
GlaxoSmithKline Biologicals SA
NDC Codes
1
Dosage Forms
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients
NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.